- Home
- DHT vs FTRE Comparison
DHT vs FTRE Comparison
Compare DHT & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHT
- FTRE
- Stock Information
- Founded
- DHT 2005
- FTRE 1996
- Country
- DHT Bermuda
- FTRE United States
- Employees
- DHT N/A
- FTRE N/A
- Industry
- DHT Marine Transportation
- FTRE Medical Specialities
- Sector
- DHT Consumer Discretionary
- FTRE Health Care
- Exchange
- DHT Nasdaq
- FTRE Nasdaq
- Market Cap
- DHT 1.7B
- FTRE 1.9B
- IPO Year
- DHT 2005
- FTRE N/A
- Fundamental
- Price
- DHT $10.76
- FTRE $17.69
- Analyst Decision
- DHT Strong Buy
- FTRE Hold
- Analyst Count
- DHT 4
- FTRE 11
- Target Price
- DHT $14.50
- FTRE $23.30
- AVG Volume (30 Days)
- DHT 1.7M
- FTRE 944.5K
- Earning Date
- DHT 02-04-2025
- FTRE 03-10-2025
- Dividend Yield
- DHT 9.29%
- FTRE N/A
- EPS Growth
- DHT N/A
- FTRE N/A
- EPS
- DHT 1.00
- FTRE N/A
- Revenue
- DHT $583,758,000.00
- FTRE $2,975,600,000.00
- Revenue This Year
- DHT N/A
- FTRE N/A
- Revenue Next Year
- DHT $5.02
- FTRE $1.09
- P/E Ratio
- DHT $10.76
- FTRE N/A
- Revenue Growth
- DHT N/A
- FTRE 2.80
- 52 Week Low
- DHT $8.67
- FTRE $16.53
- 52 Week High
- DHT $12.80
- FTRE $41.02
- Technical
- Relative Strength Index (RSI)
- DHT 61.48
- FTRE 39.63
- Support Level
- DHT $10.79
- FTRE $16.94
- Resistance Level
- DHT $11.41
- FTRE $18.52
- Average True Range (ATR)
- DHT 0.34
- FTRE 0.98
- MACD
- DHT 0.19
- FTRE -0.10
- Stochastic Oscillator
- DHT 72.34
- FTRE 22.59
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. It is an independent crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. It generates revenues from time charter and spot market operations. Its fleets consist of very large crude carriers known as VLCCs that range in size from 270,000 to 320,000 deadweight tons. Geographically, DHT operates in Monaco, Oslo, Norway, and Singapore. The company generates the majority of its revenue from the shipping revenues.
About FTRE Fortrea Holdings Inc.
Fortrea Holdings is a late-stage contract research organization, or CRO, that provides comprehensive Phase I through IV clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.